Cargando…

Emotional Dysfunction in Parkinson’s Disease

In addition to motor symptomatology, idiopathic Parkinson’s disease is characterized by emotional dysfunction. Depression affects some 30 to 40 percent of Parkinson patients and other psychiatric co-morbidities include anxiety and apathy. Neuropsychological and neuroimaging studies of emotional dysf...

Descripción completa

Detalles Bibliográficos
Autores principales: Blonder, Lee X., Slevin, John T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177157/
https://www.ncbi.nlm.nih.gov/pubmed/21876260
http://dx.doi.org/10.3233/BEN-2011-0329
_version_ 1782212272097067008
author Blonder, Lee X.
Slevin, John T.
author_facet Blonder, Lee X.
Slevin, John T.
author_sort Blonder, Lee X.
collection PubMed
description In addition to motor symptomatology, idiopathic Parkinson’s disease is characterized by emotional dysfunction. Depression affects some 30 to 40 percent of Parkinson patients and other psychiatric co-morbidities include anxiety and apathy. Neuropsychological and neuroimaging studies of emotional dysfunction in Parkinson patients suggest abnormalities involving mesolimbic and mesocortical dopaminergic pathways. There is also evidence suggesting that the interaction between serotonin and dopamine systems is important in the understanding and treatment of mood disorders in Parkinson’s disease. In this review we discuss the neuropsychiatric abnormalities that accompany Parkinson's disease and describe their neuropsychological, neuropharmacologic, and neuroimaging concomitants.
format Online
Article
Text
id pubmed-3177157
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-31771572011-09-21 Emotional Dysfunction in Parkinson’s Disease Blonder, Lee X. Slevin, John T. Behav Neurol Research Article In addition to motor symptomatology, idiopathic Parkinson’s disease is characterized by emotional dysfunction. Depression affects some 30 to 40 percent of Parkinson patients and other psychiatric co-morbidities include anxiety and apathy. Neuropsychological and neuroimaging studies of emotional dysfunction in Parkinson patients suggest abnormalities involving mesolimbic and mesocortical dopaminergic pathways. There is also evidence suggesting that the interaction between serotonin and dopamine systems is important in the understanding and treatment of mood disorders in Parkinson’s disease. In this review we discuss the neuropsychiatric abnormalities that accompany Parkinson's disease and describe their neuropsychological, neuropharmacologic, and neuroimaging concomitants. IOS Press 2011 2011-08-29 /pmc/articles/PMC3177157/ /pubmed/21876260 http://dx.doi.org/10.3233/BEN-2011-0329 Text en Copyright © 2011 Hindawi Publishing Corporation and the authors. http://creativecommons.org/licenses/by/3.0 This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Blonder, Lee X.
Slevin, John T.
Emotional Dysfunction in Parkinson’s Disease
title Emotional Dysfunction in Parkinson’s Disease
title_full Emotional Dysfunction in Parkinson’s Disease
title_fullStr Emotional Dysfunction in Parkinson’s Disease
title_full_unstemmed Emotional Dysfunction in Parkinson’s Disease
title_short Emotional Dysfunction in Parkinson’s Disease
title_sort emotional dysfunction in parkinson’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177157/
https://www.ncbi.nlm.nih.gov/pubmed/21876260
http://dx.doi.org/10.3233/BEN-2011-0329
work_keys_str_mv AT blonderleex emotionaldysfunctioninparkinsonsdisease
AT slevinjohnt emotionaldysfunctioninparkinsonsdisease